Clinical Trial Update: Biseko Versus Albumin in Systemic Inflammatory Response Syndrome (SIRS) Patients [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing Biseko versus Albumin in patients with systemic inflammatory response syndrome has completed. The update provides no results in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Inflammatory Response Syndrome

Drugs mentioned

• Albumin
• Biseko

Snippet

Sponsor: Medical University of Vienna | Conditions: Systemic Inflammatory Response Syndrome | Phase 4 | Status: COMPLETED